BrokenPromise
AI-designed drugs in clinical trials by the end of 2025
“Hassabis had said last year the company would have AI-designed drugs in clinical trials by the end of 2025.”
Context: Demis Hassabis's 2025 statement, as recalled by Reuters (via CNA, Jan 21, 2026).
How we judge it
Our interpretation: Isomorphic Labs doses the first human in a clinical trial of an AI-designed drug by 31 Dec 2025.
Resolution criteria are our interpretation of the claim, written before grading. Methodology
- Said
- Resolve by
- Verdict
- Broken ()
- Stated probability
- None stated
- Specificity
- 3 of 3 (precise and measurable)
- Score
- 0.0 points × weight 3
Evidence & grader’s note
In January 2026, Hassabis moved the target for the first trials to the end of 2026, so the end-2025 target was missed.
